Trials / Completed
CompletedNCT03055052
Clinical Effects of a Formula With Modified Protein Levels and Fat Blend in Preterm Infants
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 33 Weeks
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effects of infant formula with higher protein level and improved fat blend on growth and feeding tolerance in preterm infants. Half of the subjects will receive a standard infant formula, while the other half will receive a infant formula with a higher protein level and improved fat blend.
Detailed description
When an infant is born prematurely, the supply of nutrients supporting normal growth and development is interrupted. There is less time to accrue adequate nutrient stores and foetal tissue. The nutritional goal for the preterm infant is to have satisfactory functional development and catch up on growth to match the rate of a full term infant. To achieve this, it is recommended for the infant to have adequate protein intake and suitable fat blend.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Standard formula for preterm infants | Reconstituted in water and given to infants at more than 50% of feedings. |
| OTHER | Formula with higher protein and new fat blend for preterm infants | Reconstituted in water and given to infants at more than 50% of feedings. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-03-18
- Completion
- 2018-06-25
- First posted
- 2017-02-16
- Last updated
- 2018-08-03
Locations
1 site across 1 country: Vietnam
Source: ClinicalTrials.gov record NCT03055052. Inclusion in this directory is not an endorsement.